OXYTOCIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oxytocin, and when can generic versions of Oxytocin launch?
Oxytocin is a drug marketed by Dr Reddys, Fresenius Kabi Usa, Hikma, Hikma Farmaceutica, Sagent Pharms Inc, and Abbott. and is included in six NDAs.
The generic ingredient in OXYTOCIN is oxytocin. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the oxytocin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oxytocin
A generic version of OXYTOCIN was approved as oxytocin by HIKMA on January 10th, 2007.
Summary for OXYTOCIN
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 59 |
| Clinical Trials: | 752 |
| Patent Applications: | 5,144 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for OXYTOCIN |
| What excipients (inactive ingredients) are in OXYTOCIN? | OXYTOCIN excipients list |
| DailyMed Link: | OXYTOCIN at DailyMed |
Recent Clinical Trials for OXYTOCIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Florida | Early Phase 1 |
| Shalvata Mental Health Center | Phase 1 |
| Qianfoshan Hospital | N/A |
Pharmacology for OXYTOCIN
| Drug Class | Oxytocic |
| Physiological Effect | Increased Uterine Smooth Muscle Contraction or Tone |
Medical Subject Heading (MeSH) Categories for OXYTOCIN
Anatomical Therapeutic Chemical (ATC) Classes for OXYTOCIN
US Patents and Regulatory Information for OXYTOCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys | OXYTOCIN | oxytocin | INJECTABLE;INJECTION | 077453-001 | Jan 24, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Hikma | OXYTOCIN | oxytocin | INJECTABLE;INJECTION | 018243-002 | Jan 10, 2007 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Fresenius Kabi Usa | OXYTOCIN | oxytocin | INJECTABLE;INJECTION | 018248-002 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Abbott | OXYTOCIN 10 USP UNITS IN DEXTROSE 5% | oxytocin | INJECTABLE;INJECTION | 019185-003 | Mar 29, 1985 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Hikma Farmaceutica | OXYTOCIN | oxytocin | INJECTABLE;INJECTION | 200219-001 | Feb 13, 2013 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
